Filter

161 - 170 of 357 Results

  • KFF COVID-19 Vaccine Monitor: September 2021

    Poll Finding

    This report finds that 72% of adults now report being at least partially vaccinated for COVID-19, with the surge in cases, hospitalizations, and deaths due to the Delta variant being the main motivator for the recently vaccinated. It also examines the public's views on vaccine mandates, booster doses, and breakthrough infections.

  • Medicaid Policy Approaches to Facilitating Access to Vaccines for Low-Income Children

    Policy Watch

    Following the recent US Food & Drug Administration’s (FDA) authorization and the Centers for Disease Control and Prevention’s (CDC) recommendation, children ages 5-11 are now eligible to receive Pfizer-BioNTech’s COVID-19 vaccine. There may be unique challenges to vaccinating young children, particularly those from low-income families who may face additional barriers to access. State Medicaid programs and Medicaid managed care plans are looking at a range of policy options to facilitate access to vaccines for young, low-income children.

  • KFF COVID-19 Vaccine Monitor: July 2022

    Poll Finding

    In the wake of the FDA's emergency use authorization for COVID-19 vaccines for children ages 6 months through 4 years old, many parents remain hesitant to vaccinate their children in this age group, with a slight majority saying they view the vaccine as a bigger risk to their child's health than getting infected with coronavirus.

  • KFF COVID-19 Vaccine Monitor: July 2021

    Poll Finding

    This Vaccine Monitor report finds little change since June in the share of adults who either received a COVID-19 vaccine or say they will as soon as they can. A quarter of unvaccinated adults say they likely will get a shot by the end of the year. Unvaccinated adults are much less worried than vaccinated ones about the Delta variant.

  • Private Health Coverage of COVID-19: Key Facts and Issues

    Issue Brief

    New federal legislation will require most private health plans to cover testing for the coronavirus with no cost sharing. Some states have adopted similar requirements for insurers they regulate, and many private insurance companies will voluntarily expand coverage for testing. However, some private coverage will not be subject to these requirements. To date, fewer changes have been adopted or considered with respect to treatment for complications from the disease. This brief reviews current coverage standards for private health plans and how these may change in response to the COVID-19 pandemic.